Orphan Drugs Now “Where the Money Is,” Says Willie Sutton’s Ghost
Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer.
Pharma Marketing News Vol. 10, No. 6: 30 MARCH 2011
Welcome to Volume 10, Issue #6 (30 MARCH 2011) of Pharma Marketing News.
Physician Participation in Peer-to-Peer Social Media Sites
This article summaries research data exploring why physicians interested in using online peer-to-peer social communities outnumber by 2 to 1 physicians who are actually using them. Includes suggestions for what these communities must do in order to provide more value to physicians.
Pharma Marketing News Vol. 10, No. 3: 17 FEBRUARY 2011
Welcome to Volume 10, Issue #3 (17 FEBRUARY 2011) of Pharma Marketing News.
Pharma Spending on Internet, DTC, and Docs
How much money the pharmaceutical industry spends on Internet marketing, direct-to-consumer advertising, and physician detailing are always topics of interest and 2010 was no exception. 2010 was, however, a turning point in bringing more attention to payments made to physicians for speaking, consulting, and research.
The Pharmaguy Social Media Timeline&trade: A Record of Social Media Events Impacting the Pharmaceutical...
The long-awaited social media guidance from the FDA -- whenever it arrives -- may turn out to be nothing more than a stamp of approval on activities in which the industry is currently engaged. Practically every issue that FDA guidance is expected to address has already been handled independently by a few pioneering pharmaceutical companies. Rather than waiting for FDA's anti climatic guidelines, Pharmaguy decided to publish The Pharmaguy Social Media Timeline™ now, at a time when the industry already has set precedents in every social media application.
Pharma Marketing News Vol. 10, No. 13: 23 August 2011
Welcome to Volume 10, Issue #13 (23 AUGUST 2011) of Pharma Marketing News.
Pharma Marketing News Vol. 10, No. 7: 15 April 2011
Welcome to Volume 10, Issue #7 (15 APRIL 2011) of Pharma Marketing News.
Pharma TeleWeb e-Detailing
This article summarizes Eli Lilly's European experience using TeleWeb e-detailing, which combines a personal sales rep phone call with Web site surfing.
Limiting Bias in Commercially Supported CME
Many critics of pharma-supported CME believe this support leads to bias. Between 9 May 2011 and 13 September 2011, readers of Pharma Marketing News were asked to answer a few short questions relating to potential bias in industry-supported CME programs and how to limit the need for industry funding of CME. The results are summarized in this article.
